WallStreetZenWallStreetZen

How to Buy Autolus Therapeutics Stock

Autolus Therapeutics PLC

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer.

Autolus Therapeutics stock last closed at $6.38, up 2.24% from the previous day, and has increased 264.57% in one year. It has overperformed other stocks in the Biotechnology industry by 2.69 percentage points. Autolus Therapeutics stock is currently +296.27% from its 52-week low of $1.61, and -14.36% from its 52-week high of $7.45.

As of Mar 28, 2024, there are 265.93M shares of AUTL outstanding. The market value of AUTL is $1.70B. In the past 24 hours, 695,027 AUTL shares were traded.

How to Buy Autolus Therapeutics Stock

Not sure how to invest in Autolus Therapeutics stock? Here's how.
  1. Decide where to buy Autolus Therapeutics stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you figure out where to buy Autolus Therapeutics stock.
  2. Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Deposit funds into your investment account: Pick your payment method and add your information.
  4. Research Autolus Therapeutics stock: The Autolus Therapeutics ticker symbol is AUTL. Is Autolus Therapeutics stock a good investment? Should you buy shares of AUTL? How do AUTL's underlying business fundamentals look? Do top analysts think Autolus Therapeutics is a good buy? Why has AUTL's stock price moved recently? (Hint: Our stock market research website can help you understand if AUTL is a good stock to buy).
  5. Place your AUTL purchase: Decide if you will purchase AUTL shares at the current market price or use a limit order to buy AUTL shares at a given price.
  6. Monitor your AUTL investment: Create a watchlist to important updates regarding your new investment in Autolus Therapeutics stock.

Step 1: Decide where to buy Autolus Therapeutics stock

You need a brokerage account to access the NASDAQ market and buy AUTL stock.

A brokerage account allows you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our analysis, eToro is the best brokerage. Here's why:

  • You can invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
  • Access to world markets: From Tech to Energy, New York to Tokyo — you can fill your portfolio with stocks from the world's leading stock exchanges.
  • Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of shares by opening an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for a brokerage account

Now that you've selected your brokerage, it's time to fill out some personal details so you can invest in AUTL stock today.

How to Set Up a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal data to open a new brokerage account.
  1. Submit your details by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your investment account

Now that you've finished signing up on the stocks app, your next step is to transfer the money for your investment:

Watch this video walkthrough to see the process of depositing funds into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Autolus Therapeutics stock

Once you have decided on the best place to buy Autolus Therapeutics stock, it's critical to analyze their stock prior to buying, so you truly understand the risk and upside.

Autolus Therapeutics stock data

AUTL Price
$6.38
1w %
2.08%
1y %
264.57%
5y %
-78.9%
P/E
-5.32x
P/B
15.22x
P/S
638x
PEG
N/A
Revenue
$1.70M
Earnings
-$208.38M
Fore. Rev. Growth
380.86%
Fore. Earn. Growth
N/A
Market Cap
$1.70B
Next Earnings
May 1, 2024
Next Dividend
N/A

AUTL Zen Score

WallStreetZen was created to help part-time investors perform better fundamental analysis in minutes instead of hours.

You can view all of the due diligence checks on AUTL's stock page.

What is the fair value of AUTL stock?

You can use a variety of different financial metrics, analyses, models, and charts to gauge AUTL's true value.

Using relative valuations measures:

  • AUTL may be overvalued based on its P/B ratio of 15.22x, relative to Biotechnology industry P/B ratio of 6.21x

You can do more valuation research on AUTL's stock here.

AUTL Financial Health Summary

Passed Health Checks:

  • AUTL has cash burn of 156573000. It has sufficient cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than long-term liabilities on the AUTL balance sheet.
  • There are more short-term assets than short-term liabilities on the AUTL balance sheet.

Failed Health Checks:

  • Total AUTL debt is higher than 5 years ago, relative to shareholder equity.
  • AUTL has $240.34M in cash and short term investments. This is not enough to cover its annual cash burn of $156.57M.
  • AUTL has a relatively high debt to equity ratio of 2.37.
  • AUTL profit margin has gone down from -2,340.2% to -12,272.3% in the past year.

Is it a good time to buy Autolus Therapeutics stock, according to Wall Street analysts?

Out of 2 Wall Street analysts who give recommendations on AUTL, the consensus analyst rating on AUTL is a Strong Buy

Please note that analyst ratings are not stock recommendations, nor are they investment advice.

You can dive deeper into what analysts are projecting on the Autolus Therapeutics stock forecast page.

AUTL Technicals

SMA10
6.25
SMA20
5.95
SMA50
6.12
SMA100
5.6
SMA200
4.18
MACD
0.07
MACD Signal
0
MACD Histogram
0.06
RSI
56.06
Stochastic %K
72.7
Stochastic %D
72.54
StochRSI %K
70.92
StochRSI %D
71.98

AUTL Performance Numbers

Last year, AUTL revenue was $1.70M. During the past five year, AUTL's revenue has grown by 2.9% per year. This was slower than the Biotechnology industry average of 29.51%.

You can analyze AUTL's earnings and revenue performance here.

What are AUTL insiders up to?

In the last year, executives and large shareholders at AUTL have not bought or sold any shares.

Research more about who owns AUTL shares here.

Can I rely on AUTL as an income stream?

No, Autolus Therapeutics doesn't provide an income stream by paying out dividends.

What do other investors have to say about AUTL?

One of the major reasons eToro is our favorite brokerage is because of its social trading community.

Click below to see what other investors have to say.

Step 5: Place your AUTL purchase

You have two primary types of orders:

  • Market order: A market order is an order to buy or sell a stock at the best possible price.
    Market orders are usually fine for most investors.
  • Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
    If you want to ensure you're buying or selling at a specific dollar amount, place a limit order.

Click the Open Trade button and eToro will place your order.

If you want additional info about buying stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Monitor your AUTL investment

Now that you own some AUTL shares, you'll want to stay up-to-date on your new investment.

Add AUTL to a watchlist to get notified of the latest news about your AUTL stock.

AUTL Feed

How to Buy Stock in Autolus Therapeutics

To reiterate, here are the 6 steps to buy stock in Autolus Therapeutics:

  1. Decide where to buy Autolus Therapeutics stock
  2. Sign up for a brokerage account
  3. Deposit funds into your investment account
  4. Research Autolus Therapeutics stock
  5. Place your AUTL purchase
  6. Monitor your AUTL investment

If you need a online brokerage, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to keep an eye on your new investment in Autolus Therapeutics, click the button below.

NASDAQ: AUTL
$6.38+0.14 (+2.24%)
Updated Mar 28, 2024
Open eToro Account
NASDAQ: AUTL
$6.38+0.14 (+2.24%)
Updated Mar 28, 2024
Open eToro Account

FAQ

How much does it cost to buy one Autolus Therapeutics share?

As of Mar 28, 2024, it costs $6.38 to buy one share of Autolus Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $3, you can buy 0.47 shares of AUTL.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Autolus Therapeutics stock?

According to 2 Wall Street analysts who monitor Autolus Therapeutics, their consensus recommendation is to buy Autolus Therapeutics stock.

What is the best way to buy Autolus Therapeutics stock?

One way to place an order for Autolus Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.